Fundraising FoxAdvanced ENT Solutions
Menlo Park, US · Founded 2016 · Delaware corporation
Find your way into Advanced ENT Solutions
Sign up to see every warm intro you have to Advanced ENT Solutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Advanced ENT Solutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JS
Joshua ShermanExecutive
AA
Amir AbolfathiNamed on SEC filing
Board
DM
David McIntyreBoard director
SH
Sami HamadeBoard director
RR
Renee RyanBoard director
Reported raises · per SEC filings
Form D private placements$53.5M disclosed across 6 rounds · 2016–2019
▶$2MraisedOct 2019 · 1 investors · BiotechnologyRule 506(b)
▶$2MraisedOct 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amir AbolfathiExecutive Officer, Director
- Seth HarrisonDirector
- Jon WaldstreicherDirector
- Offering amount
- $5M
- Amount sold
- $2M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$4MraisedJul 2019 · 1 investors · BiotechnologyRule 506(b)
▶$4MraisedJul 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David McIntyreDirector
- Seth HarrisonDirector
- Amir AbolfathiExecutive Officer, Director
- Jon WaldstreicherDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$13MraisedSep 2018 · 1 investors · BiotechnologyRule 506(b)
▶$13MraisedSep 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amir AbolfathiExecutive Officer, Director
- Joshua ShermanExecutive Officer
- Jon WaldstreicherDirector
- David McIntyreDirector
- Offering amount
- $13M
- Amount sold
- $13M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$7MraisedApr 2018 · 1 investors · BiotechnologyRule 506(b)
▶$7MraisedApr 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jon WaldstreicherDirector
- Joshua ShermanExecutive Officer
- Amir AbolfathiExecutive Officer, Director
- David McIntyreDirector
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$10.2MraisedJun 2017 · 1 investors · BiotechnologyRule 506(b)
▶$10.2MraisedJun 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joshua ShermanExecutive Officer
- Amir AbolfathiExecutive Officer, Director
- David McIntyreDirector
- Sami HamadeDirector
- Offering amount
- $18M
- Amount sold
- $10.2M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$17.3MraisedFeb 2016 · 2 investors · OtherRule 506(b)
▶$17.3MraisedFeb 2016 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Joshua ShermanExecutive Officer
- David McIntyreDirector
- Sami HamadeDirector
- Renee RyanDirector
- Amir AbolfathiExecutive Officer
- Offering amount
- $17.3M
- Amount sold
- $17.3M
- Minimum investment
- $1
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Advanced ENT Solutions raised?
- Advanced ENT Solutions has disclosed $53.5M raised across 6 rounds.
- Where is Advanced ENT Solutions headquartered?
- Advanced ENT Solutions is headquartered in Menlo Park, US.